Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Agammaglobulinemia × plerixafor × Clear all

Phase

Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Warts 1 Neutropenia 1 Infections 1 Immunologic Deficiency Syndromes 1 Agammaglobulinemia 1

Interventions

plerixafor 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Immunoglobulins 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Clavulanic Acid 1 Ciprofloxacin 1 Amoxicillin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02231879 2023-04-07

Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome

National Institutes of Health Clinical Center (CC)

Phase 2/3 Completed

20 enrolled 10 charts

Agammaglobulinemia, Immunologic Deficiency Syndromes, Infections, Neutropenia, Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡